{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:50:06Z","timestamp":1784872206232,"version":"3.55.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05648-4","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:27:54Z","timestamp":1763548074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safeguarding artemisinin: integrating bioproduction innovation and resistance management for malaria eradication"],"prefix":"10.1186","volume":"24","author":[{"given":"Karim","family":"Farmanpour Kalalagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Hazrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousan","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Davarpanah Dizaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Tariverdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Beyraghdar Kashkooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"5648_CR1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11101-016-9480-2","volume":"15","author":"DY Xie","year":"2016","unstructured":"Xie DY, Ma DM, Judd R, Jones AL. Artemisinin biosynthesis in Artemisia annua and metabolic engineering: questions, challenges, and perspectives. Phytochem Rev. 2016;15:1093\u2013114.","journal-title":"Phytochem Rev"},{"key":"5648_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpls.2017.01966","volume":"8","author":"NKBK Ikram","year":"2017","unstructured":"Ikram NKBK, Simonsen HT. A review of biotechnological artemisinin production in plants. Front Plant Sci. 2017;8:1\u201310.","journal-title":"Front Plant Sci"},{"key":"5648_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-3305-3-5","volume":"3","author":"FE Cox","year":"2010","unstructured":"Cox FE. History of the discovery of the malaria parasites and their vectors. Parasit Vectors. 2010;3:5.","journal-title":"Parasit Vectors"},{"key":"5648_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ymben.2016.07.004","volume":"38","author":"B Wang","year":"2016","unstructured":"Wang B, Beyraghdar Kashkooli A, Sallets A, Ting HM, de Ruijter NCA, Olofsson L, et al. Transient production of artemisinin in Nicotiana benthamiana is boosted by a specific lipid transfer protein from A. annua. Metab Eng. 2016;38:159\u201369.","journal-title":"Metab Eng"},{"key":"5648_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00299-014-1566-y","volume":"33","author":"K Tang","year":"2014","unstructured":"Tang K, Shen Q, Yan T, Fu X. Transgenic approach to increase artemisinin content in Artemisia annua L. Plant Cell Rep. 2014;33:605\u201315.","journal-title":"Plant Cell Rep"},{"key":"5648_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2016.69","volume":"7","author":"C Dou","year":"2016","unstructured":"Dou C, Ding N, Xing J, Zhao C, Kang F, Hou T, et al. Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway. Cell Death Dis. 2016;7:1\u20139.","journal-title":"Cell Death Dis"},{"key":"5648_CR7","first-page":"1","volume":"12","author":"BK Rakhmanov","year":"2025","unstructured":"Rakhmanov BK, Usmonov DE, Imamkhodjaeva AS, Zakiryaeva SI, Ubaydullaeva KA, Shermatov SE, et al. Therapeutic potential of Artemisia annua and artemisinin in viral infections, cancer and global health advancements. Plant Sci Today. 2025;12:1\u20139.","journal-title":"Plant Sci Today"},{"key":"5648_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2022.780257","volume":"13","author":"K Farmanpour-Kalalagh","year":"2022","unstructured":"Farmanpour-Kalalagh K, Beyraghdar Kashkooli A, Babaei A, Rezaei A, van der Krol AR. Artemisinins in combating viral infections like SARS-CoV-2, inflammation and cancers and options to meet increased global demand. Front Plant Sci. 2022;13:780257.","journal-title":"Front Plant Sci"},{"key":"5648_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3732\/ajb.1300329","volume":"101","author":"HY Wetzstein","year":"2014","unstructured":"Wetzstein HY, Porter JA, Janick J, Ferreira JFS. Flower morphology and floral sequence in Artemisia annua (Asteraceae). Am J Bot. 2014;101:875\u201385.","journal-title":"Am J Bot"},{"key":"5648_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/plants13071050","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang J, Shi T, Wang H, Li M, Zhang X, Huang L. Estimating the amount of the wild Artemisia annua in China based on the MaxEnt model and spatio-temporal kriging interpolation. Plants. 2024;13:1050.","journal-title":"Plants"},{"key":"5648_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.indcrop.2012.02.018","volume":"39","author":"EA Brisibe","year":"2012","unstructured":"Brisibe EA, Udensi O, Chukwurah PN, de Magalh\u00e4es PM, Figueira GM, Ferreira JFS. Adaptation and agronomic performance of Artemisia annua L. under lowland humid tropical conditions. Ind Crops Prod. 2012;39:190\u20137.","journal-title":"Ind Crops Prod"},{"key":"5648_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymben.2019.01.007","volume":"54","author":"A Beyraghdar Kashkooli","year":"2019","unstructured":"Beyraghdar Kashkooli A, van der Krol AR, Rabe P, Dickschat JS, Bouwmeester H. Substrate promiscuity of enzymes from the sesquiterpene biosynthetic pathways from Artemisia annua and Tanacetum parthenium allows for novel combinatorial sesquiterpene production. Metab Eng. 2019;54:12\u201323.","journal-title":"Metab Eng"},{"key":"5648_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/cdt.2016.10.05","volume":"6","author":"W Liu","year":"2016","unstructured":"Liu W, Liu Y. Youyou Tu: significance of winning the 2015 Nobel Prize in physiology or medicine. Cardiovasc Diagn Ther. 2016;6:1\u20132.","journal-title":"Cardiovasc Diagn Ther"},{"key":"5648_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11427-015-4948-7","volume":"58","author":"XZ Su","year":"2015","unstructured":"Su XZ, Miller LH. The discovery of artemisinin and the Nobel prize in physiology or medicine. Sci China Life Sci. 2015;58:1175\u20139.","journal-title":"Sci China Life Sci"},{"key":"5648_CR15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2471","volume":"17","author":"Y Tu","year":"2011","unstructured":"Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217\u201320.","journal-title":"Nat Med"},{"key":"5648_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985;228:1049\u201355.","journal-title":"Science"},{"key":"5648_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12936-016-1312-8","volume":"15","author":"BH Kiani","year":"2016","unstructured":"Kiani BH, Suberu J, Mirza B. Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin. Malar J. 2016;15:252.","journal-title":"Malar J"},{"key":"5648_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.indcrop.2010.10.001","volume":"33","author":"C Lei","year":"2011","unstructured":"Lei C, Ma D, Pu G, Qiu X, Du Z, Wang H, et al. Foliar application of chitosan activates artemisinin biosynthesis in Artemisia. Ind Crop Prod. 2011;33:176\u201382.","journal-title":"Ind Crop Prod"},{"key":"5648_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11240-013-0413-0","volume":"116","author":"N Pandey","year":"2014","unstructured":"Pandey N, Pandey-Rai S. Short term UV-B radiation-mediated transcriptional responses and altered secondary metabolism of in vitro propagated plantlets of Artemisia annua L. Plant Cell Tissue Organ Cult. 2014;116:371\u201385.","journal-title":"Plant Cell Tissue Organ Cult"},{"key":"5648_CR20","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.2174\/092986708786242813","volume":"15","author":"P Arsenault","year":"2008","unstructured":"Arsenault P, Wobbe K, Weathers P. Recent advances in artemisinin production through heterologous expression. Curr Med Chem. 2008;15:2886\u201396.","journal-title":"Curr Med Chem"},{"key":"5648_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fbioe.2017.00047","volume":"5","author":"NKBK Ikram","year":"2017","unstructured":"Ikram NKBK, Beyraghdar Kashkooli A, Peramuna AV, van der Krol AR, Bouwmeester H, Simonsen HT. Stable production of the antimalarial drug artemisinin in the moss Physcomitrella patens. Front Bioeng Biotechnol. 2017;5:47.","journal-title":"Front Bioeng Biotechnol"},{"key":"5648_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2229-11-45","volume":"11","author":"L Olofsson","year":"2011","unstructured":"Olofsson L, Engstr\u00f6m A, Lundgren A, Brodelius PE. Relative expression of genes of terpene metabolism in different tissues of Artemisia annua L. BMC Plant Biol. 2011;11:45.","journal-title":"BMC Plant Biol"},{"key":"5648_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-arplant-050312-120116","volume":"64","author":"E Vranova","year":"2013","unstructured":"Vranova E, Coman D, Gruissem W. Network analysis of the MVA and MEP pathways for isoprenoid synthesis. Annu Rev Plant Biol. 2013;64:665\u2013700.","journal-title":"Annu Rev Plant Biol"},{"key":"5648_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13664","volume":"5","author":"P Fuentes","year":"2016","unstructured":"Fuentes P, Zhou F, Erban A, Karcher D, Kopka J, Bock R. A new synthetic biology approach allows transfer of an entire metabolic pathway from a medicinal plant to a biomass crop. Elife. 2016;5:e13664.","journal-title":"Elife"},{"key":"5648_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/abbi.2000.1962","volume":"381","author":"P Mercke","year":"2000","unstructured":"Mercke P, Bengtsson M, Bouwmeester HJ, Posthumus MA, Brodelius PE. Molecular cloning, expression, and characterization of amorpha-4,11-diene synthase, a key enzyme of artemisinin biosynthesis in Artemisia annua L. Arch Biochem Biophys. 2000;381:173\u201380.","journal-title":"Arch Biochem Biophys"},{"key":"5648_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/s-2005-837749","volume":"71","author":"C Bertea","year":"2005","unstructured":"Bertea C, Freije J, van der Woude H, Verstappen FW, Perk L, Marquez V, et al. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med. 2005;71:40\u20137.","journal-title":"Planta Med"},{"key":"5648_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature12051","volume":"496","author":"CJ Paddon","year":"2013","unstructured":"Paddon CJ, Westfall PJ, Pitera DJ, Benjamin K, Fisher K, McPhee D, et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature. 2013;496:528\u201332.","journal-title":"Nature"},{"key":"5648_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.febslet.2006.01.065","volume":"580","author":"KH Teoh","year":"2006","unstructured":"Teoh KH, Polichuk DR, Reed DW, Nowak G, Covello PS. Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. FEBS Lett. 2006;580:1411\u20136.","journal-title":"FEBS Lett"},{"key":"5648_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nature04640","volume":"440","author":"DK Ro","year":"2006","unstructured":"Ro DK, Paradise EM, Quellet M, Fisher KJ, Newman KL, Ndungu JM, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006;440:940\u20133.","journal-title":"Nature"},{"key":"5648_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.phytochem.2009.10.015","volume":"71","author":"N Schramek","year":"2010","unstructured":"Schramek N, Wang H, R\u00f6misch-Margl W, Keil B, Radykewicz T, Winzenh\u00f6rlein B, et al. Artemisinin biosynthesis in growing plants of Artemisia annua. Phytochemistry. 2010;71:179\u201387.","journal-title":"Phytochemistry"},{"key":"5648_CR31","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1038\/s41467-025-59312-1","volume":"16","author":"Z Guo","year":"2025","unstructured":"Guo Z, Zhou Y, Li J, Liu D, Huang Y, Zhang Y. Dihydroartemisinic acid dehydrogenase- mediated alternative route for artemisinin biosynthesis. Nat Commun. 2025;16:3888.","journal-title":"Nat Commun"},{"key":"5648_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.phytochem.2014.02.011","volume":"102","author":"J Han","year":"2014","unstructured":"Han J, Wang H, Lundgren A, Brodelius PE. Effects of overexpression of AaWRKY1 on artemisinin biosynthesis in transgenic Artemisia annua plants. Phytochemistry. 2014;102:89\u201396.","journal-title":"Phytochemistry"},{"key":"5648_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1182612","volume":"327","author":"LA Graham","year":"2010","unstructured":"Graham LA, Besser K, Blumer S, Branigan CA, Czechowski T, Elias L, et al. The genetic map of Artemisia annua L identifies loci affecting yield of the antimalarial drug artemisinin. Science. 2010;327:328\u201331.","journal-title":"Science"},{"key":"5648_CR34","doi-asserted-by":"publisher","first-page":"1099713","DOI":"10.3389\/fpls.2022.1099713","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Yang H, Han T, Kim HS, Marcelis LFM. Towards greenhouse cultivation of Artemisia annua: the application of LEDs in regulating plant growth and secondary metabolism. Front Plant Sci. 2023;13:1099713.","journal-title":"Front Plant Sci"},{"key":"5648_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/bab.13","volume":"58","author":"X Lin","year":"2011","unstructured":"Lin X, Zhou Y, Zhang J, Lu X, Zhang F, Shen Q, et al. Enhancement of artemisinin content in tetraploid Artemisia annua plants by modulating the expression of genes in artemisinin biosynthetic pathway. Biotechnol Appl Biochem. 2011;58:50\u20137.","journal-title":"Biotechnol Appl Biochem"},{"key":"5648_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.stress.2025.100757","volume":"15","author":"A Tripathi","year":"2025","unstructured":"Tripathi A, Pandey P, Tripathi SN, Kalra A. Plant growth-promoting endophytic consortium improved artemisinin biosynthesis via modulating antioxidants, gene expression, and transcriptional profile in Artemisia annua (L.) under stressed environments. Plant Stress. 2025;15:100757.","journal-title":"Plant Stress"},{"key":"5648_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/horticulturae8070597","volume":"8","author":"N Golubkina","year":"2022","unstructured":"Golubkina N, Logvinenko L, Konovalov D, Garsiya E, Fedotov M, Alpatov A, et al. Foliar application of selenium under nano silicon on Artemisia annua: effects on yield, antioxidant status, essential oil, artemisinin content and mineral composition. Horticulturae. 2022;8:597.","journal-title":"Horticulturae"},{"key":"5648_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jplph.2022.153712","volume":"274","author":"Y Li","year":"2022","unstructured":"Li Y, Chen T, Liu H, Qin W, Yan X, Wu-Zhang K, et al. The truncated AaActin1 promoter is a candidate tool for metabolic engineering of artemisinin biosynthesis in Artemisia annua L. J Plant Physiol. 2022;274:153712.","journal-title":"J Plant Physiol"},{"key":"5648_CR39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00299-010-0967-9","volume":"30","author":"B Liu","year":"2011","unstructured":"Liu B, Wang H, Du Z, Li G, Ye H. Metabolic engineering of artemisinin biosynthesis in Artemisia annua L. Plant Cell Rep. 2011;30:689\u201394.","journal-title":"Plant Cell Rep"},{"key":"5648_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/hr\/uhad292","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Yang Y, Li L, Tang K, Hao X, Kai G. Advanced metabolic engineering strategies for increasing artemisinin yield in Artemisia annua L. Hortic Res. 2024;11:uhad292.","journal-title":"Hortic Res"},{"key":"5648_CR41","doi-asserted-by":"publisher","first-page":"1118082","DOI":"10.3389\/fpls.2023.1118082","volume":"14","author":"D Hassani","year":"2023","unstructured":"Hassani D, Taheri A, Fu X, Qin W, Hang L, Ma Y, et al. Elevation of artemisinin content by co-transformation of artemisinin biosynthetic pathway genes and trichome-specific transcription factors in Artemisia annua. Front Plant Sci. 2023;14:1118082.","journal-title":"Front Plant Sci"},{"key":"5648_CR42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.molp.2019.02.011","volume":"12","author":"R Judd","year":"2019","unstructured":"Judd R, Bagley MC, Li M, Zhu Y, Lei C, Yuzuak S, et al. Artemisinin biosynthesis in non-glandular trichome cells of Artemisia annua. Mol Plant. 2019;12:704\u201314.","journal-title":"Mol Plant"},{"key":"5648_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136291","volume":"281","author":"F Qamar","year":"2024","unstructured":"Qamar F, Mishra A, Ashrafi K, Saifi M, Dash PK, Kumar S, et al. Increased artemisinin production in Artemisia annua L. by co-overexpression of six key biosynthetic enzymes. Int J Biol Macromol. 2024;281:136291.","journal-title":"Int J Biol Macromol"},{"key":"5648_CR44","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/jipb.13258","volume":"64","author":"Z Lv","year":"2022","unstructured":"Lv Z, Li JX, Qiu S, Qi F, Su H, Bu Q, et al. The transcription factors TLR1 and TLR2 negatively regulate trichome density and artemisinin levels in Artemisia annua. J Integr Plant Biol. 2022;64:1212\u201328.","journal-title":"J Integr Plant Biol"},{"key":"5648_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/ppl.14581","volume":"176","author":"RA Khan","year":"2024","unstructured":"Khan RA, Kumar A, Abbas N. A bHLH transcription factor AaMYC2-type positively regulates glandular trichome density and artemisinin biosynthesis in Artemisia annua. Physiol Plant. 2024;176:e14581.","journal-title":"Physiol Plant"},{"key":"5648_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.molp.2015.04.002","volume":"8","author":"H Tan","year":"2015","unstructured":"Tan H, Xiao L, Gao S, Li Q, Chen J, Xiao Y, et al. Trichome and artemisinin regulator 1 is required for trichome development and artemisinin biosynthesis in Artemisia annua. Mol Plant. 2015;8:1396\u2013411.","journal-title":"Mol Plant"},{"key":"5648_CR47","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/nph.16777","volume":"228","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Tan H, Li Q, Li Q, Wang Y, Bu Q, et al. Trichome and artemisinin regulator 2 positively regulates trichome development and artemisinin biosynthesis in Artemisia annua. New Phytol. 2020;228:932\u201345.","journal-title":"New Phytol"},{"key":"5648_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/ppl.13849","volume":"175","author":"HIM Mohammad","year":"2023","unstructured":"Mohammad HIM, Kumar A, Abbas N. Synergistic interaction of two bHLH transcription factors positively regulates artemisinin biosynthetic pathway in Artemisia annua L. Physiol Plant. 2023;175:e13849.","journal-title":"Physiol Plant"},{"key":"5648_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/nph.14373","volume":"214","author":"M Chen","year":"2017","unstructured":"Chen M, Yan T, Shen Q, Lu X, Pan Q, Huang Y, et al. Glandular trichome-specific wrky 1 promotes artemisinin biosynthesis in Artemisia annua. New Phytol. 2017;214:304\u201316.","journal-title":"New Phytol"},{"key":"5648_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/pbi.14449","volume":"23","author":"M Yuan","year":"2025","unstructured":"Yuan M, Sheng Y, Bao J, Wu W, Nie G, Wang L, et al. AaMYC3 bridges the regulation of glandular trichome density and artemisinin biosynthesis in Artemisia annua. Plant Biotechnol J. 2025;23:315\u201332.","journal-title":"Plant Biotechnol J"},{"key":"5648_CR51","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/nph.12207","volume":"198","author":"X Lu","year":"2013","unstructured":"Lu X, Zhang L, Zhang F, Jiang W, Shen Q, Zhang L, et al. AaORA, a trichome-specific AP2\/ERF transcription factor of Artemisia annua, is a positive regulator in the artemisinin biosynthetic pathway and in disease resistance to Botrytis cinerea. New Phytol. 2013;198:1191\u2013202.","journal-title":"New Phytol"},{"key":"5648_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.657156","volume":"12","author":"W Qin","year":"2021","unstructured":"Qin W, Xie L, Li Y, Liu H, Fu X, Chen T, et al. An R2R3-MYB transcription factor positively regulates the glandular secretory trichome initiation in Artemisia annua L. Front Plant Sci. 2021;12:657156.","journal-title":"Front Plant Sci"},{"key":"5648_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612929","volume":"24","author":"H Liu","year":"2023","unstructured":"Liu H, He W, Yao X, Yan X, Wang X, Peng B, et al. The light- and jasmonic acid-induced AaMYB108-like positive regulates the initiation of glandular secretory trichome in Artemisia annua L. Int J Mol Sci. 2023;24:12929.","journal-title":"Int J Mol Sci"},{"key":"5648_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014222","volume":"5","author":"TWJM van Herpen","year":"2010","unstructured":"van Herpen TWJM, Cankar K, Nogueira M, Bosch D, Bouwmeester HJ, Beekwilder J. Nicotiana benthamiana as a production platform for artemisinin precursors. PLoS ONE. 2010;5:e14222.","journal-title":"PLoS ONE"},{"key":"5648_CR55","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4719","volume":"13","author":"NKK Ikram","year":"2023","unstructured":"Ikram NKK, Beyraghdar Kashkooli A, Peramuna AV, van der Krol AR, Bouwmeester H, Simonsen HT. Heterologous production of artemisinin in Physcomitrium patens by direct in vivo assembly of multiple DNA fragments. Bio Protocol. 2023;13:e4719.","journal-title":"Bio Protocol"},{"key":"5648_CR56","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.3390\/molecules24213822","volume":"24","author":"NKK Ikram","year":"2019","unstructured":"Ikram NKK, Beyraghdar Kashkooli A, Peramuna A, Van Der Krol AR, Bouwmeester H, Simonsen HT. Insights into heterologous biosynthesis of arteannuin B and artemisinin in Physcomitrella patens. Molecules. 2019;24:3822.","journal-title":"Molecules"},{"key":"5648_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/op4003196","volume":"18","author":"J Turconi","year":"2014","unstructured":"Turconi J, Guevel R, Oddon G, Villa R, Geatti A, Hvala M, et al. Semisynthetic artemisinin, the chemical path to industrial production. Org Process Res Dev. 2014;18:417\u201322.","journal-title":"Org Process Res Dev"},{"key":"5648_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cej.2016.02.085","volume":"294","author":"A Burgard","year":"2016","unstructured":"Burgard A, Gieshoff T, Peschl A, H\u00f6rstermann D, Keleschovsky C, Villa R, et al. Optimisation of the photochemical oxidation step in the industrial synthesis of artemisinin. Chem Eng J. 2016;294:83\u201396.","journal-title":"Chem Eng J"},{"key":"5648_CR59","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/530390a","volume":"530","author":"M Peplow","year":"2016","unstructured":"Peplow M. Synthetic malaria drug meets market resistance. Nature. 2016;530:389\u201390.","journal-title":"Nature"},{"key":"5648_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.00087","volume":"9","author":"SH Kung","year":"2018","unstructured":"Kung SH, Lund S, Murarka A, Mcphee D, Paddon CJ. Approaches and recent developments for the commercial production of semi-synthetic artemisinin. Front Plant Sci. 2018;9:87.","journal-title":"Front Plant Sci"},{"key":"5648_CR61","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nbt833","volume":"21","author":"VJ Martin","year":"2003","unstructured":"Martin VJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol. 2003;21:796\u2013802.","journal-title":"Nat Biotechnol"},{"key":"5648_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004489","volume":"4","author":"H Tsuruta","year":"2009","unstructured":"Tsuruta H, Paddon CJ, Eng D, Lenihan JR, Horning T, Anthony LC, et al. High-level production of amorpha-4, 11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS ONE. 2009;4:e4489.","journal-title":"PLoS ONE"},{"key":"5648_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mec.2019.e00121","volume":"10","author":"M Marsafari","year":"2020","unstructured":"Marsafari M, Xu P. Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in Yarrowia lipolytica. Metab Eng Commun. 2020;10:e00121.","journal-title":"Metab Eng Commun"},{"key":"5648_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nbt.2020.10.007","volume":"60","author":"H Pramastya","year":"2021","unstructured":"Pramastya H, Xue D, Abdallah II, Setroikromo R, Quax WJ. High level production of amorphadiene using Bacillus subtilis as an optimized terpenoid cell factory. N Biotechnol. 2021;60:159\u201367.","journal-title":"N Biotechnol"},{"key":"5648_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40643-017-0164-6","volume":"4","author":"H Yu","year":"2017","unstructured":"Yu H, Zhu B, Zhan Y. Microbial transformation of artemisinin by Aspergillus terreus. Bioresour Bioprocess. 2017;4:33.","journal-title":"Bioresour Bioprocess"},{"key":"5648_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26334-3","volume":"8","author":"LR Runtuwene","year":"2018","unstructured":"Runtuwene LR, Tuda JSB, Mongan AE, Makalowski W, Frith MC, Imwong M, et al. Nanopore sequencing of drug-resistance-associated genes in malaria parasites, Plasmodium falciparum. Sci Rep. 2018;8:8286.","journal-title":"Sci Rep"},{"key":"5648_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2015.05.004","volume":"27","author":"C Cui","year":"2015","unstructured":"Cui C, Feng H, Shi X, Wang Y, Feng Z, Liu J, et al. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor \u03b21 and interleukin-10. Int Immunopharmacol. 2015;27:110\u201321.","journal-title":"Int Immunopharmacol"},{"key":"5648_CR68","unstructured":"WHO. World Malaria Report 2024. Geneva, World Health Organization, 2024."},{"key":"5648_CR69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/science.aax4735","volume":"367","author":"J Birnbaum","year":"2020","unstructured":"Birnbaum J, Scharf S, Schmidt S, Jonscher E, Maria Hoeijmakers WA, Flemming S, et al. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science. 2020;367:51\u20139.","journal-title":"Science"},{"key":"5648_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12936-017-1845-5","volume":"16","author":"A Mukherjee","year":"2017","unstructured":"Mukherjee A, Bopp S, Magistrado P, Wong W, Daniels R, Demas A, et al. Artemisinin resistance without Pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malar J. 2017;16:195.","journal-title":"Malar J"},{"key":"5648_CR71","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.pt.2019.09.005","volume":"35","author":"AM Talman","year":"2019","unstructured":"Talman AM, Clain J, Duval R, M\u00e9nard R, Ariey F. Artemisinin bioactivity and resistance in malaria parasites. Trends Parasitol. 2019;35:953\u201363.","journal-title":"Trends Parasitol"},{"key":"5648_CR72","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1038\/s41598-020-63283-2","volume":"10","author":"S Romphosri","year":"2020","unstructured":"Romphosri S, Changruenngam S, Chookajorn T, Modchang C. Role of a concentration gradient in malaria drug resistance evolution: a combined within- and between-hosts modelling approach. Sci Rep. 2020;10:6219.","journal-title":"Sci Rep"},{"key":"5648_CR73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","volume":"22","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Conrad MD. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat Rev Microbiol. 2024;22:373\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"5648_CR74","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Bailey JA, Conrad MD, Ishengoma DS, Kamya MR, et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis. 2024;24:e591\u2013600.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR75","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1475-2875-12-118","volume":"12","author":"G Henriques","year":"2013","unstructured":"Henriques G, Martinelli A, Rodrigues L, Modrzynska K, Fawcett R, Houston DR, et al. Artemisinin resistance in rodent malaria-mutation in the AP2 adaptor \u03bc-chain suggests involvement of endocytosis and membrane protein trafficking. Malar J. 2013;12:118.","journal-title":"Malar J"},{"key":"5648_CR76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-6851(99)00148-6","volume":"104","author":"D Syafruddin","year":"1999","unstructured":"Syafruddin D, Siregar JE, Marzuki S. Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone. Mol Biochem Parasitol. 1999;104:185\u201394.","journal-title":"Mol Biochem Parasitol"},{"key":"5648_CR77","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"5648_CR78","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","volume":"585","author":"I Petersen","year":"2011","unstructured":"Petersen I, Eastman R, Lanzer M. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011;585:1551\u201362.","journal-title":"FEBS Lett"},{"key":"5648_CR79","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"5648_CR80","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","volume":"347","author":"S Mok","year":"2014","unstructured":"Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science. 2014;347:431\u20135.","journal-title":"Science"},{"key":"5648_CR81","first-page":"406","volume":"129","author":"SC Xie","year":"2016","unstructured":"Xie SC, Dogovski C, Hanssen E, Chiu F, Yang T, Crespo MP, et al. Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins. J Cell Sci. 2016;129:406\u201316.","journal-title":"J Cell Sci"},{"key":"5648_CR82","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41598-020-79539-w","volume":"11","author":"M Rawat","year":"2021","unstructured":"Rawat M, Kanyal A, Sahasrabudhe A, Vembar SS, Lopez-Rubio J-J, Karmodiya K. Histone acetyltransferase PfGCN5 regulates stress responsive and artemisinin resistance related genes in Plasmodium falciparum. Sci Rep. 2021;11:852.","journal-title":"Sci Rep"},{"key":"5648_CR83","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520:683\u20137.","journal-title":"Nature"},{"key":"5648_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002132","volume":"13","author":"C Dogovski","year":"2015","unstructured":"Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, et al. Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance. PLoS Biol. 2015;13:e1002132.","journal-title":"PLoS Biol"},{"key":"5648_CR85","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","volume":"29","author":"T Yang","year":"2019","unstructured":"Yang T, Yeoh LM, Tutor MV, Dixon MW, McMillan PJ, Xie SC, et al. Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance. Cell Rep. 2019;29:2917\u201328.","journal-title":"Cell Rep"},{"key":"5648_CR86","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1038\/s41467-018-07588-x","volume":"9","author":"L Zhu","year":"2018","unstructured":"Zhu L, Tripathi J, Rocamora FM, Miotto O, van der Pluijm R, Voss TS, et al. The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background. Nat Commun. 2018;9:5158.","journal-title":"Nat Commun"},{"key":"5648_CR87","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, Macinnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"5648_CR88","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12936-018-2532-x","volume":"17","author":"KF Breglio","year":"2018","unstructured":"Breglio KF, Amato R, Eastman R, Lim P, Sa JM, Guha R, et al. A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation. Malar J. 2018;17:391.","journal-title":"Malar J"},{"key":"5648_CR89","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.pt.2020.03.006","volume":"36","author":"SC Xie","year":"2020","unstructured":"Xie SC, Ralph SA, Tilley L. K13, the cytostome, and artemisinin resistance. Trends Parasitol. 2020;36:533\u201344.","journal-title":"Trends Parasitol"},{"key":"5648_CR90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5648_CR91","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"5648_CR92","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar K, Bhattacharjee S, Safeukui I. Drug resistance in Plasmodium. Nat Rev Microbiol. 2018;16:156\u201370.","journal-title":"Nat Rev Microbiol"},{"key":"5648_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008482","volume":"16","author":"NF Gn\u00e4dig","year":"2020","unstructured":"Gn\u00e4dig NF, Stokes BH, Edwards RL, Kalantarov GF, Heimsch KC, Kuderjavy M, et al. Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13. PLoS Pathog. 2020;16:e1008482.","journal-title":"PLoS Pathog"},{"key":"5648_CR94","doi-asserted-by":"publisher","first-page":"e01134","DOI":"10.1128\/mBio.01134-19","volume":"11","author":"FA Siddiqui","year":"2020","unstructured":"Siddiqui FA, Boonhok R, Cabrera M, Mbenda HGN, Wang M, Min H, et al. Role of Plasmodium falciparum Kelch 13 protein mutations in P. falciparum populations from Northeastern Myanmar in mediating artemisinin resistance. MBio. 2020;11:e01134-e1219.","journal-title":"MBio"},{"key":"5648_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104275","volume":"146","author":"J Na\u00df","year":"2019","unstructured":"Na\u00df J, Efferth T. Development of artemisinin resistance in malaria therapy. Pharmacol Res. 2019;146:104275.","journal-title":"Pharmacol Res"},{"key":"5648_CR96","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/emboj.2013.173","volume":"32","author":"P Genschik","year":"2013","unstructured":"Genschik P, Sumara I, Lechner E. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. EMBO J. 2013;32:2307\u201320.","journal-title":"EMBO J"},{"key":"5648_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-7-13","volume":"7","author":"BS Dhanoa","year":"2013","unstructured":"Dhanoa BS, Cogliati T, Satish AG, Bruford EA, Friedman JS. Update on the Kelch-like (KLHL) gene family. Hum Genomics. 2013;7:13.","journal-title":"Hum Genomics"},{"key":"5648_CR98","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jmii.2019.07.006","volume":"53","author":"MT Zaw","year":"2020","unstructured":"Zaw MT, Lin Z, Emran NA. Importance of Kelch 13 C580Y mutation in the studies of artemisinin resistance in Plasmodium falciparum in Greater Mekong Subregion. J Microbiol Immunol Infect. 2020;53:676\u201381.","journal-title":"J Microbiol Immunol Infect"},{"key":"5648_CR99","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QCO.0000000000000199","volume":"28","author":"RM Fairhurst","year":"2015","unstructured":"Fairhurst RM. Understanding artemisinin-resistant malaria: what a difference a year makes. Curr Opin Infect Dis. 2015;28:417\u201325.","journal-title":"Curr Opin Infect Dis"},{"key":"5648_CR100","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coph.2018.06.003","volume":"42","author":"N Suresh","year":"2018","unstructured":"Suresh N, Haldar K. Mechanisms of artemisinin resistance in Plasmodium falciparum malaria. Curr Opin Pharmacol. 2018;42:46\u201354.","journal-title":"Curr Opin Pharmacol"},{"key":"5648_CR102","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1038\/s41467-023-39914-3","volume":"14","author":"TD Nguyen","year":"2023","unstructured":"Nguyen TD, Gao B, Amaratunga C, Dhorda M, Tran TNA, White NJ, et al. Preventing antimalarial drug resistance with triple artemisinin-based combination therapies. Nat Commun. 2023;14:4568.","journal-title":"Nat Commun"},{"key":"5648_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002200","volume":"3","author":"TD Nguyen","year":"2023","unstructured":"Nguyen TD, Tran TN-A, Parker DM, White NJ, Boni MF. Antimalarial mass drug administration in large populations and the evolution of drug resistance. PLoS Glob Public Health. 2023;3:e0002200.","journal-title":"PLoS Glob Public Health"},{"key":"5648_CR104","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/QCO.0000000000000766","volume":"34","author":"M Dhorda","year":"2021","unstructured":"Dhorda M, Amaratunga C, Dondorp AM. Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination. Curr Opin Infect Dis. 2021;34:432\u20139.","journal-title":"Curr Opin Infect Dis"},{"key":"5648_CR105","volume":"26","author":"O M\u00fcller","year":"2019","unstructured":"M\u00fcller O, Lu GY, Von Seidlein L. Geographic expansion of artemisinin resistance. J Travel Med. 2019;26:taz030.","journal-title":"J Travel Med"},{"key":"5648_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004789","volume":"11","author":"E Talundzic","year":"2015","unstructured":"Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 2015;11:e1004789.","journal-title":"PLoS Pathog"},{"key":"5648_CR107","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S1473-3099(12)70241-4","volume":"12","author":"AO Talisuna","year":"2012","unstructured":"Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, et al. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis. 2012;12:888\u201396.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR108","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/jac\/dkae120","volume":"79","author":"N Fukuda","year":"2024","unstructured":"Fukuda N, Yoshida N, Balikagala B, Tsuru I, Ikeda M, Hirai M, et al. Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance. J Antimicrob Chemother. 2024;79:1418\u201322.","journal-title":"J Antimicrob Chemother"},{"key":"5648_CR109","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5648_CR110","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13059-017-1204-4","volume":"18","author":"GC Cerqueira","year":"2017","unstructured":"Cerqueira GC, Cheeseman IH, Schaffner SF, Nair S, McDew-White M, Phyo AP, et al. Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance. Genome Biol. 2017;18:78.","journal-title":"Genome Biol"},{"key":"5648_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197369","volume":"13","author":"C Prosser","year":"2018","unstructured":"Prosser C, Meyer W, Ellis J, Lee R. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016). PLoS ONE. 2018;13:e0197369.","journal-title":"PLoS ONE"},{"key":"5648_CR112","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR113","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"5648_CR114","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00436-018-6126-x","volume":"118","author":"R Pasupureddy","year":"2019","unstructured":"Pasupureddy R, Atul, Seshadri S, Pande V, Dixit R, Pandey KC. Current scenario and future strategies to fight artemisinin resistance. Parasitol Res. 2019;118:29\u201342.","journal-title":"Parasitol Res"},{"key":"5648_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2019.04.016","volume":"74","author":"PG Mathenge","year":"2020","unstructured":"Mathenge PG, Low SK, Vuong NL, Mohamed MYF, Faraj HA, Alieldin GI, et al. Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis. Parasitol Int. 2020;74:101919.","journal-title":"Parasitol Int"},{"key":"5648_CR116","doi-asserted-by":"crossref","unstructured":"Hafiz A, Alam MA, Alghamdi OA, Mohammed A. Combination therapy and multidrug resistance in malaria parasite. Comb Ther Against Multidrug Resist. 2020. p. 141\u201356.","DOI":"10.1016\/B978-0-12-820576-1.00008-4"},{"key":"5648_CR117","doi-asserted-by":"publisher","first-page":"e02137","DOI":"10.1128\/AAC.02137-20","volume":"65","author":"KA Ribbiso","year":"2021","unstructured":"Ribbiso KA, Heller LE, Taye A, Julian E, Willems AV, Roepe PD. Artemisinin-based drugs target the Plasmodium falciparum heme detoxification pathway. Antimicrob Agents Chemother. 2021;65:e02137-e2220.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"5648_CR119","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01234-19","volume":"63","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Nsobya SL, Rosenthal PJ. The diversity of the Plasmodium falciparum K13 propeller domain did not increase after implementation of artemisinin-based combination therapy in Uganda. Antimicrob Agents Chemother. 2019;63:e01234\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/tropicalmed4010026","volume":"4","author":"C Nsanzabana","year":"2019","unstructured":"Nsanzabana C. Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug! Trop Med Infect Dis. 2019;4:26.","journal-title":"Trop Med Infect Dis"},{"key":"5648_CR121","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"5648_CR122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1051\/parasite\/2018021","volume":"25","author":"M Ouji","year":"2018","unstructured":"Ouji M, Augereau JM, Paloque L, Benoit-Vical F. Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination. Parasite. 2018;25:24.","journal-title":"Parasite"},{"key":"5648_CR123","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1475-2875-9-56","volume":"9","author":"SY Whegang","year":"2010","unstructured":"Whegang SY, Tahar R, Foumane VN, Soula G, Gw\u00e9t H, Thalabard JC, et al. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malar J. 2010;9:56.","journal-title":"Malar J"},{"key":"5648_CR124","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","volume":"105","author":"L Moriarty","year":"2021","unstructured":"Moriarty L, Nkoli P, Likwela J, Mulopo P, Sompwe \u00c9, Rika J, et al. Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial resistance. Am J Trop Med Hyg. 2021;105:1067\u201375.","journal-title":"Am J Trop Med Hyg"},{"key":"5648_CR125","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12936-018-2524-x","volume":"17","author":"MA Kakolwa","year":"2018","unstructured":"Kakolwa MA, Mahende MK, Ishengoma DS, Mandara CI, Ngasala B, Kamugisha E, et al. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in mainland Tanzania. Malar J. 2018;17:369.","journal-title":"Malar J"},{"key":"5648_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65553-5","volume":"10","author":"MA Diallo","year":"2020","unstructured":"Diallo MA, Yade MS, Ndiaye YD, Diallo I, Diongue K, Sy SA, et al. Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Sci Rep. 2020;10:8907.","journal-title":"Sci Rep"},{"key":"5648_CR127","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1039\/D0NP00079E","volume":"38","author":"HN Lyu","year":"2021","unstructured":"Lyu HN, Ma N, Meng Y, Zhang X, Wong YK, Xu C, et al. Study towards improving artemisinin-based combination therapies. Nat Prod Rep. 2021;38:1243\u201350.","journal-title":"Nat Prod Rep"},{"key":"5648_CR128","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.actatropica.2005.06.009","volume":"95","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop. 2005;95:305\u201315.","journal-title":"Acta Trop"},{"key":"5648_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06018-6","volume":"21","author":"W Shibeshi","year":"2021","unstructured":"Shibeshi W, Baye AM, Alemkere G, Engidawork E. Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:326.","journal-title":"BMC Infect Dis"},{"key":"5648_CR130","doi-asserted-by":"publisher","first-page":"e01068","DOI":"10.1128\/AAC.01068-18","volume":"62","author":"S Dini","year":"2018","unstructured":"Dini S, Zaloumis S, Cao P, Price RN, Fowkes FJI, Rob W, et al. Investigating the efficacy of triple artemisinin-based combination therapies for treating Plasmodium falciparum malaria patients using mathematical modeling. Antimicrob Agents Chemother. 2018;62:e01068-e1118.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR131","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12936-021-03762-7","volume":"20","author":"S Krishna","year":"2021","unstructured":"Krishna S, Mishra S, Tiwari P, Vishwakarma AK, Khandai S, Shrivastava S, et al. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India. Malar J. 2021;20:229.","journal-title":"Malar J"},{"key":"5648_CR132","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1473-3099(22)00208-0","volume":"22","author":"RW van der Pluijm","year":"2022","unstructured":"van der Pluijm RW, Peto TJ, Hamaluba M, Callery JJ, Tripura R, White NJ, et al. Is triple artemisinin-based combination therapy necessary for uncomplicated malaria? Lancet Infect Dis. 2022;22:585\u20136.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR133","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12936-024-04844-y","volume":"23","author":"E Kokori","year":"2024","unstructured":"Kokori E, Olatunji G, Akinboade A, Akinoso A, Egbunu E, Aremu SA, et al. Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts. Malar J. 2024;23:25.","journal-title":"Malar J"},{"key":"5648_CR134","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/trstmh\/tru199","volume":"109","author":"GD Shanks","year":"2015","unstructured":"Shanks GD, Edstein MD, Jacobus D. Evolution from double to triple-antimalarial drug combinations. Trans R Soc Trop Med Hyg. 2015;109:182\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5648_CR135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11908-017-0579-4","volume":"19","author":"B Dipanjan","year":"2017","unstructured":"Dipanjan B, Shivaprakash G, Balaji O. Triple combination therapy and drug cycling-tangential strategies for countering artemisinin resistance. Curr Infect Dis Rep. 2017;19:25.","journal-title":"Curr Infect Dis Rep"},{"key":"5648_CR136","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pt.2017.01.004","volume":"33","author":"AM Dondorp","year":"2017","unstructured":"Dondorp AM, Smithuis FM, Woodrow C, von Seidlein L. How to contain artemisinin- and multidrug-resistant falciparum malaria. Trends Parasitol. 2017;33:353\u201363.","journal-title":"Trends Parasitol"},{"key":"5648_CR137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12688\/wellcomeopenres.16065.1","volume":"6","author":"P Tindana","year":"2021","unstructured":"Tindana P, de Haan F, Mokuolu OA, Guissou R, Bolarinwa OA, Ouedraogo JB, et al. Ethical, regulatory and market related aspects of deploying triple artemisinin-based combination therapies for malaria treatment in Africa: a study protocol. Wellcome Open Res. 2021;6:75.","journal-title":"Wellcome Open Res"},{"key":"5648_CR138","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s12889-022-13212-x","volume":"22","author":"F de Haan","year":"2022","unstructured":"de Haan F, Boon WPC, Amaratunga C, Dondorp AM. Expert perspectives on the introduction of triple artemisinin-based combination therapies (TACTs) in Southeast Asia: a Delphi study. BMC Public Health. 2022;22:864.","journal-title":"BMC Public Health"},{"key":"5648_CR139","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12936-019-2955-z","volume":"18","author":"NJ White","year":"2019","unstructured":"White NJ. Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance. Malar J. 2019;18:338.","journal-title":"Malar J"},{"key":"5648_CR140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/expr.2001.4659","volume":"100","author":"S Gupta","year":"2002","unstructured":"Gupta S, Thapar MM, Mariga ST, Wernsdorfer WH, Bj\u00f6rkman A. Plasmodium falciparum: In vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Exp Parasitol. 2002;100:28\u201335.","journal-title":"Exp Parasitol"},{"key":"5648_CR141","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1475-2875-8-196","volume":"8","author":"FW Hombhanje","year":"2009","unstructured":"Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, et al. Artemisinin-naphthoquine combination (ARCO\u2122) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J. 2009;8:196.","journal-title":"Malar J"},{"key":"5648_CR142","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1128\/AAC.06248-11","volume":"56","author":"J Benjamin","year":"2012","unstructured":"Benjamin J, Moore B, Lee ST, Senn M, Griffin S, Lautu D, et al. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Antimicrob Agents Chemother. 2012;56:2465\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR143","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1128\/AAC.06250-11","volume":"56","author":"KT Batty","year":"2012","unstructured":"Batty KT, Salman S, Moore BR, Benjamin J, Lee ST, Page-Sharp M, et al. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study. Antimicrob Agents Chemother. 2012;56:2472\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR144","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/cid\/ciy364","volume":"67","author":"C Deng","year":"2018","unstructured":"Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, et al. Large-scale artemisinin-piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa. Clin Infect Dis. 2018;67:1670\u20136.","journal-title":"Clin Infect Dis"},{"key":"5648_CR145","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","volume":"17","author":"JJ Walsh","year":"2007","unstructured":"Walsh JJ, Coughlan D, Heneghan N, Gaynor C, Bell A. A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorganic Med Chem Lett. 2007;17:3599\u2013602.","journal-title":"Bioorganic Med Chem Lett"},{"key":"5648_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111129","volume":"14","author":"HC Quadros","year":"2021","unstructured":"Quadros HC, \u00c7apc\u0131 A, Herrmann L, D\u2019alessandro S, Fontinha D, Azevedo R, et al. Studies of potency and efficacy of an optimized artemisinin-quinoline hybrid against multiple stages of the Plasmodium life cycle. Pharmaceuticals (Basel). 2021;14:1129.","journal-title":"Pharmaceuticals (Basel)"},{"key":"5648_CR147","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1021\/jacsau.3c00716","volume":"4","author":"L Herrmann","year":"2024","unstructured":"Herrmann L, Leidenberger M, Quadros HC, Grau BW, Hampel F, Friedrich O, et al. Access to artemisinin-triazole antimalarials via organo-click reaction: high in vitro\/in vivo activity against multi-drug-resistant malaria parasites. JACS Au. 2024;4:951\u20137.","journal-title":"JACS Au"},{"key":"5648_CR148","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-019-2848-1","volume":"18","author":"B Abuaku","year":"2019","unstructured":"Abuaku B, Duah-Quashie NO, Quaye L, Matrevi SA, Quashie N, Gyasi A, et al. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015\u20132017. Malar J. 2019;18:206.","journal-title":"Malar J"},{"key":"5648_CR149","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12936-016-1381-8","volume":"15","author":"AM Dorkenoo","year":"2016","unstructured":"Dorkenoo AM, Yehadji D, Agbo YM, Layibo Y, Agbeko F, Adjeloh P, et al. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012\u20132013. Malar J. 2016;15:331.","journal-title":"Malar J"},{"key":"5648_CR150","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1128\/AAC.00365-11","volume":"55","author":"NT Chinh","year":"2011","unstructured":"Chinh NT, Quang NN, Anh CX, Thanh NX, Dai B, Birrell GW, et al. Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers. Antimicrob Agents Chemother. 2011;55:4412\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR151","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4269\/ajtmh.16-0144","volume":"95","author":"NC Phong","year":"2016","unstructured":"Phong NC, Quang HH, Thanh NX, Trung TN, Dai B, Shanks GD, et al. In vivo efficacy and tolerability of artesunate-azithromycin for the treatment of falciparum malaria in Vietnam. Am J Trop Med Hyg. 2016;95:164\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5648_CR152","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0035-9203(03)90166-0","volume":"97","author":"SB Sirima","year":"2003","unstructured":"Sirima SB, Tiono AB, Konat\u00e9 A, Diarra A, Castelli F, Pinoges L, et al. Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial. Trans R Soc Trop Med Hyg. 2003;97:345\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5648_CR153","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-3156.2003.01169.x","volume":"9","author":"CJ Drakeley","year":"2004","unstructured":"Drakeley CJ, Jawara M, Targett GAT, Walraven G, Obisike U, Coleman R, et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health. 2004;9:53\u201361.","journal-title":"Trop Med Int Health"},{"key":"5648_CR154","first-page":"145","volume":"47","author":"FA Fehintola","year":"2010","unstructured":"Fehintola FA, Balogun ST. Comparative study of efficacy of artesunate plus cotrimoxazole and artesunate plus chloroquine in the treatment of malaria in Nigerian children: a preliminary report. J Vector Borne Dis. 2010;47:145\u201350.","journal-title":"J Vector Borne Dis"},{"key":"5648_CR155","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/430309","volume":"40","author":"M Ramharter","year":"2005","unstructured":"Ramharter M, Oyakhirome S, Klouwenberg PK, Ad\u00e9gnika AA, Agnandji ST, Missinou MA, et al. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis. 2005;40:1777\u201384.","journal-title":"Clin Infect Dis"},{"key":"5648_CR156","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1128\/AAC.49.9.3749-3754.2005","volume":"49","author":"S Borrmann","year":"2005","unstructured":"Borrmann S, Adegnika AA, Moussavou F, Oyakhirome S, Esser G, Matsiegui PB, et al. Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2005;49:3749\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR157","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.2003.69.14","volume":"69","author":"U Silachamroon","year":"2003","unstructured":"Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, et al. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg. 2003;69:14\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5648_CR158","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.trstmh.2007.01.003","volume":"101","author":"NVH Dao","year":"2007","unstructured":"Dao NVH, Cuong BT, Ngoa ND, Thuy LTT, The ND, Duy DN, et al. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine. Trans R Soc Trop Med Hyg. 2007;101:534\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5648_CR159","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.actatropica.2007.12.005","volume":"105","author":"L Vivas","year":"2008","unstructured":"Vivas L, Rattray L, Stewart L, Bongard E, Robinson BL, Peters W, et al. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo. Acta Trop. 2008;105:222\u20138.","journal-title":"Acta Trop"},{"key":"5648_CR160","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2875-12-70","volume":"12","author":"S Duparc","year":"2013","unstructured":"Duparc S, Borghini-Fuhrer I, Craft CJ, Arbe-Barnes S, Miller RM, Shin CS, et al. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar J. 2013;12:70.","journal-title":"Malar J"},{"key":"5648_CR161","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","volume":"16","author":"I Sagara","year":"2016","unstructured":"Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. Lancet Infect Dis. 2016;16:189\u201398.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR162","first-page":"522","volume":"27","author":"K Na-Bangchang","year":"1996","unstructured":"Na-Bangchang K, Kanda T, Tipawangso P, Thanavibul A, Suprakob K, Ibrahim M, et al. Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health. 1996;27:522\u20135.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5648_CR163","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-019-2730-1","volume":"18","author":"DS Ishengoma","year":"2019","unstructured":"Ishengoma DS, Mandara CI, Francis F, Talundzic E, Lucchi NW, Ngasala B, et al. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania. Malar J. 2019;18:88.","journal-title":"Malar J"},{"key":"5648_CR164","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1365-2125.1997.00604.x","volume":"43","author":"K Na-Bangchang","year":"1997","unstructured":"Na-Bangchang K, Congpuong K, Sirichaisinthop J, Suprakorb K, Karbwang J, Karbwang J. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria. Br J Clin Pharmacol. 1997;43:639\u201342.","journal-title":"Br J Clin Pharmacol"},{"key":"5648_CR165","first-page":"308","volume":"19","author":"JR Huang","year":"2001","unstructured":"Huang JR, Gao YQ, Elie N. A study of artemether combined with primaquine in the treatment of falciparum malaria. Chin J Parasitol Parasit Dis. 2001;19:308\u20139.","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"5648_CR166","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2017.11.002","volume":"123","author":"S Dawre","year":"2018","unstructured":"Dawre S, Pathak S, Sharma S, Devarajan PV. Enhanced antimalalarial activity of a prolonged release in situ gel of arteether\u2013lumefantrine in a murine model. Eur J Pharm Biopharm. 2018;123:95\u2013107.","journal-title":"Eur J Pharm Biopharm"},{"key":"5648_CR167","first-page":"216","volume":"3","author":"A Pareek","year":"2008","unstructured":"Pareek A, Padmanaban G, Vathsala PG, Chandurkar N, Payghan R. In vivo antimalarial activity of oral beta-arteether and piperaquine combination. Pharmacolonline. 2008;3:216\u201326.","journal-title":"Pharmacolonline"},{"key":"5648_CR168","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12916-024-03787-0","volume":"22","author":"AN Abd-Rahman","year":"2024","unstructured":"Abd-Rahman AN, Kaschek D, K\u00fcmmel A, Webster R, Pottera AJ, Odedra A, et al. Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood stage Plasmodium falciparum. BMC Med. 2024;22:563.","journal-title":"BMC Med"},{"key":"5648_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26868","volume":"10","author":"PA Odera","year":"2024","unstructured":"Odera PA, Otieno G, Onyango JO, Owuor JJ, Oloo FA, Ongas M, et al. Nanoparticle-based formulation of dihydroartemisinin-lumefantrine duo-drugs: preclinical evaluation and enhanced antimalarial efficacy in a mouse model. Heliyon. 2024;10:e26868.","journal-title":"Heliyon"},{"key":"5648_CR170","first-page":"525","volume":"33","author":"S Krudsood","year":"2002","unstructured":"Krudsood S, Buchachart K, Chalermrut K, Charusabha C, Treeprasertsuk S, Haoharn O, et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. Southeast Asian J Trop Med Public Health. 2002;33:525\u201331.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5648_CR171","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1128\/AAC.47.11.3494-3499.2003","volume":"47","author":"M Ramharter","year":"2003","unstructured":"Ramharter M, Noedl H, Winkler H, Graninger W, Wernsdorfer WH, Kremsner PG, et al. In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum. Antimicrob Agents Chemother. 2003;47:3494\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR172","first-page":"23","volume":"36","author":"K Na-Bangchang","year":"2005","unstructured":"Na-Bangchang K, Thanavibul A, Tippawangkosol P, Karbwang J. Pharmacokinetics of the four combination regimens of dihydroartemisinin\/mefloquine in acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health. 2005;36:23\u201333.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5648_CR173","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12936-019-3047-9","volume":"18","author":"L Pull","year":"2019","unstructured":"Pull L, Lupoglazoff JM, Beardmore M, Michel JF, Buffet P, Bouchaud O, et al. Artenimol-piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort. Malar J. 2019;18:419.","journal-title":"Malar J"},{"key":"5648_CR174","first-page":"193","volume":"20","author":"L Dequan","year":"2002","unstructured":"Dequan L, Shigan L, Xiaoping F, Wenjiang C, Zuolin C, Huimin W, et al. Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine. Chin J Parasitol Parasit Dis. 2002;20:193\u20136.","journal-title":"Chin J Parasitol Parasit Dis"},{"key":"5648_CR175","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","volume":"10","author":"F Smithuis","year":"2010","unstructured":"Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo APP, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010;10:673\u201381.","journal-title":"Lancet Infect Dis"},{"key":"5648_CR176","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/432551","volume":"192","author":"R McGready","year":"2005","unstructured":"McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis. 2005;192:846\u201353.","journal-title":"J Infect Dis"},{"key":"5648_CR177","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0035-9203(03)80040-8","volume":"97","author":"R McGready","year":"2003","unstructured":"McGready R, Keo NK, Villegas L, White NJ, Looareesuwan S, Nosten F. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg. 2003;97:592\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5648_CR178","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","volume":"210","author":"R Tahar","year":"2014","unstructured":"Tahar R, Almelli T, Debue C, Ngane VF, Allico JD, Youdom SW, et al. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. J Infect Dis. 2014;210:1962\u201371.","journal-title":"J Infect Dis"},{"key":"5648_CR179","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10156-008-0603-6","volume":"14","author":"FA Fehintola","year":"2008","unstructured":"Fehintola FA, Adedeji AA, Gbotosho GO, Happi CT, Balogun ST, Folarin OA, et al. Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children. J Infect Chemother. 2008;14:188\u201394.","journal-title":"J Infect Chemother"},{"key":"5648_CR180","doi-asserted-by":"publisher","first-page":"307","DOI":"10.7705\/biomedica.v29i2.32","volume":"29","author":"AM V\u00e1squez","year":"2009","unstructured":"V\u00e1squez AM, San\u00edn F, Alvarez LG, Tob\u00f3n A, R\u00edos A, Blair S. Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development. Biomedica. 2009;29:307\u201319.","journal-title":"Biomedica"},{"key":"5648_CR181","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01273-19","volume":"63","author":"R Leang","year":"2019","unstructured":"Leang R, Khim N, Chea H, Huy R, Mairet-Khedim M, Bouth DM, et al. Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for the treatment of malaria in Western Cambodia. Antimicrob Agents Chemother. 2019;63:e01273\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR182","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.actatropica.2007.03.004","volume":"102","author":"A Tall","year":"2007","unstructured":"Tall A, Rabarijaona LP, Robert V, Bedja SA, Ariey F, Randrianarivelojosia M. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union. Acta Trop. 2007;102:176\u201381.","journal-title":"Acta Trop"},{"issue":"1","key":"5648_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-4-41","volume":"4","author":"SB Elamin","year":"2005","unstructured":"Elamin SB, Malik EM, Abdelgadir T, Khamiss AH, Mohammed MM, Ahmed ES, et al. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J. 2005;4(1):41.","journal-title":"Malar J"},{"key":"5648_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0611-9","volume":"14","author":"CC John","year":"2016","unstructured":"John CC. Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk. BMC Med. 2016;14:65.","journal-title":"BMC Med"},{"key":"5648_CR185","first-page":"316","volume":"34","author":"S Krudsood","year":"2003","unstructured":"Krudsood S, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertsuk S, et al. Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP\u00ae) and artemether-lumefantrine (Coartem\u00ae\/Riamet\u00ae) in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health. 2003;34:316\u201321.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"5648_CR186","first-page":"e00060","volume":"25","author":"B Hanboonkunupakarn","year":"2019","unstructured":"Hanboonkunupakarn B, Van Der Pluijm RW, Hoglund R, Pukrittayakamee S, Winterberg M, Mukaka M, et al. Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults. Antimicrob Agents Chemother. 2019;25:e00060-e119.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR187","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/infdis\/jit407","volume":"208","author":"AP Pasaribu","year":"2013","unstructured":"Pasaribu AP, Chokejindachai W, Sirivichayakul C, Tanomsing N, Chavez I, Tjitra E, et al. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combinedwith primaquine for radical treatment of vivax malaria in Sumatera, Indonesia. J Infect Dis. 2013;208:1906\u201313.","journal-title":"J Infect Dis"},{"key":"5648_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-185","volume":"10","author":"H Menan","year":"2011","unstructured":"Menan H, Faye O, Same-Ekobo A, Oga ASS, Faye B, Kiki Barro CP, et al. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal. Malar J. 2011;10:185.","journal-title":"Malar J"},{"key":"5648_CR189","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1128\/AAC.01135-09","volume":"54","author":"SA Shekalaghe","year":"2010","unstructured":"Shekalaghe SA, Ter BR, Daou M, Kavishe R, Van Bijllaardt W, Den VB, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010;54:1762\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5648_CR190","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-3156.2003.01180.x","volume":"9","author":"PT Giao","year":"2004","unstructured":"Giao PT, De Vries PJ, Hung LQ, Binh TQ, Nam NV, Kager PA. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam. Trop Med Int Health. 2004;9:209\u201316.","journal-title":"Trop Med Int Health"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05648-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:03:03Z","timestamp":1763550183000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05648-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05648-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}